The possible association between Toxoplasma gondii infection and risk of anxiety and cognitive disorders in BALB/c mice

References

• Dubey JP. Toxoplasmosis-a waterborne zoonosis. Vet Parasitol. 2004;126:57–72.10.1016/j.vetpar.2004.09.005
   PubMed Web of Science ®Google Scholar
• Mahmoudvand H, Saedi Dezaki E, Soleimani S, Baneshi MR, Kheirandish F, Ezatpour B, Zia-ali N. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in southeast of Iran. Parasite Immunol. 2015;37(7):362–367.10.1111/pim.2015.37.issue-7
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). A public health approach to mental health. Geneva: 2001. Available from: http://www.who.int/whr/2001/en/whr01_ch1_en.pdf
   Google Scholar
• Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med. 2005;22(3):293–300.10.1111/dme.2005.22.issue-3
   PubMed Web of Science ®Google Scholar
• Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158:1568–1578.10.1176/appi.ajp.158.10.1568
   PubMed Web of Science ®Google Scholar
• Xian H, Chantarujikapong SI, Scherrer JF, Eisen SA, Lyons MJ, Goldberg J, et al. Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs. Drug Alcohol Depend. 2000;61:95–102.10.1016/S0376-8716(00)00127-7
   PubMed Web of Science ®Google Scholar
• Hamer D. Genetics. Rethinking behavior genetics. Science. 2002;298:71–72.10.1126/science.1077582
   PubMed Web of Science ®Google Scholar
• Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behavior disorders–overview of evidence and mechanisms. Folia Parasitol. 2010;57:105–113.10.14411/fp.2010.013
   PubMed Web of Science ®Google Scholar
• Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S. Is there any role of Toxoplasma gondii in the etiology of obsessive–compulsive disorder? Psychiatry Res. 2002;177:263–265.
   Google Scholar
• Torrey EF, Bartko JJ, Yolken RH. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull. 2012;38:642–647.10.1093/schbul/sbs043
   PubMed Web of Science ®Google Scholar
• Markovitz AA, Simanek AM, Yolken RH, Galea S, Koenen KC, Chen S, et al. Toxoplasma gondii and anxiety disorders in a community-based sample. Brain Behav Immun. 2015;43:192–197.10.1016/j.bbi.2014.08.001
   PubMed Web of Science ®Google Scholar
• Aghaei I, Shabani I, Doustar N, Nazeri M, Dehpour A. Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis. Pharmacol Biochem Behav. 2014;120:133–139.10.1016/j.pbb.2014.03.002
   PubMed Web of Science ®Google Scholar
• Fruchart J, Bastide M. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans. 2006;34:1341–1346.
   PubMed Web of Science ®Google Scholar
• Swanson CR, Joers V, Bondarenko V, Brunner K, Simmons HA, Ziegler TE, et al. The PPAR-g agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J Neuroinflammation. 2011;8:91–115.10.1186/1742-2094-8-91
   PubMed Web of Science ®Google Scholar
• Kemnitz JW, Elson DF, Roecker EB, Baum ST, Bergman RN, Meglasson MD. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes. 1994;43:204–211.10.2337/diab.43.2.204
   PubMed Web of Science ®Google Scholar
• Kemp DE, Schinagle M, Gao K, Conroy C, Ganocy SJ, Ismail-Beigi F, et al. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression. CNS Drugs. 2014;28(6):571–581.10.1007/s40263-014-0158-2
   PubMed Web of Science ®Google Scholar
• Mahmoudvand H, Ziaali N, Ghazvini H, Shojaee S, Keshavarz H, Esmaeilpour K, Sheibani V. in PressToxoplasma gondii infection promotes neuroinflammation through cytokine networks and induced hyperalgesia in BALB/c mice. Inflammation 2015 Oct 21.
   Google Scholar
• Nazeri M, Shabani M, Ghotbi Ravandi S, Aghaei I, Nozari M, Mazhari S. Psychological or physical prenatal stress differentially affects cognition behaviors. Physiol Behav. 2015;142:155–160.10.1016/j.physbeh.2015.02.016
   PubMed Web of Science ®Google Scholar
• Aghaei I, Nazeri M, Shabani M, Mossavinasab M, Mirhosseini FK, Nayebpour M, Dalili A. Erythropoietin ameliorates the motor and cognitive function impairments in a rat model of hepatic cirrhosis. Metab Brain Dis. 2015;30(1):197–204.10.1007/s11011-014-9600-x
   PubMed Web of Science ®Google Scholar
• Ha TY, Chang KA, Kim JA, Kim HS, Kim S, et al. S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576, AD animal model. PLoS One. 2010;5:e8840.10.1371/journal.pone.0008840
   PubMed Web of Science ®Google Scholar
• Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iranian J parasitool. 2012;2(1):1–17.
   Google Scholar
• Skallová A, Kodym P, Frynta D, Flegr J. The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethologicaland ethopharmacological study. Parasitology. 2006;133(5):525–535.10.1017/S0031182006000886
   PubMed Web of Science ®Google Scholar
• Zhou YH, Wang XB, Jiang SF, Xu YL, Tao JP, Zhang XP, et al. Impairment of learning and memory ability in mice with latent infection of Toxoplasma gondii. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2011;29(5):333–338.
   PubMedGoogle Scholar
• Daniels BP, Sestito SR, Rouse ST. An expanded task battery in the Morris water maze reveals effects of Toxoplasma gondii infection on learning and memory in rats. Parasitol Int. 2015;64(1):5–12.10.1016/j.parint.2014.09.002
   PubMed Web of Science ®Google Scholar
• Hodkova H, Kodym P, Flegr J. Poorer results of mice with latent toxoplasmosis in learning tests: impaired learning processes or the novelty discrimination mechanism? Parasitology. 2007;134(10):1329–1337.10.1017/S0031182007002673
   PubMed Web of Science ®Google Scholar
• Haroon F, Händel U, Angenstein F, Goldschmidt J, Kreutzmann P, Lison H, et al. Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS ONE. 2012;7:e35516.10.1371/journal.pone.0035516
   PubMed Web of Science ®Google Scholar
• Worth AR, Lymbery AJ, Thompson RC. Adaptive host manipulation by Toxoplasm gondii: fact or fiction? Trends Parasitol. 2013;29:150–155.10.1016/j.pt.2013.01.004
   PubMed Web of Science ®Google Scholar
• Gale SD, Brown BL, Berrett A, Erickson LD, Hedges DW. Association between latent toxoplasmosis and major depression, generalised anxiety disorder and panic disorder in human adults. Folia Parasitol (Praha). 2014;61(4):285–292.
   PubMed Web of Science ®Google Scholar
• Evans AK, Strassmann PS, Lee IP, Sapolsky RM. Patterns of Toxoplasma gondii cyst distribution in the forebrain associate with individual variation in predator odor avoidance and anxiety-related behavior in male Long-Evans rats. Brain Behav Immun. 2004;37:122–133.
   Google Scholar
• Zeinoddini A, Sorayani M, Hassanzadeh E, Arbabi M, Farokhnia M, Salimi S, et al. Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial. Depress Anxiety. 2015;32(3):167–173.
   PubMed Web of Science ®Google Scholar
• Kumar A, Vashist A, Kumar P. Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioural, biochemical and mitochondrial alterations in mice. Inflammopharmacology. 2010;18(5):241–251.10.1007/s10787-010-0048-2
   PubMedGoogle Scholar
• Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med. 2003;35(1):2–11.10.1080/07853890310004075
   PubMed Web of Science ®Google Scholar
• Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol. 2002;5(4):389–399.10.1017/S1461145702003152
   PubMed Web of Science ®Google Scholar
• Liesenfeld O, Parvanova I, Zerrahn J, Han SJ, Heinrich F, Muñoz M, et al. The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS ONE. 2011;6:e20568.10.1371/journal.pone.0020568
   PubMed Web of Science ®Google Scholar
• Munoz M, Liesenfeld O, Heimesaat MM. Immunology of Toxoplasma gondii. Immunol Rev. 2011;240:269–285.10.1111/imr.2011.240.issue-1
   PubMed Web of Science ®Google Scholar
• Dunn AJ. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res. 2006;6:52–68.10.1016/j.cnr.2006.04.002
   PubMed Web of Science ®Google Scholar
• McCusker RH, Kelley KW. Immune-neural connections: how the immune system’s response to infectious agents influences behavior. J Exp Biol. 2013;216:84–98.10.1242/jeb.073411
   PubMed Web of Science ®Google Scholar
• Saito K, Markey SP, Heyes MP. Chronic effects of γ-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Res. 1991;546:151–154.10.1016/0006-8993(91)91171-V
   PubMed Web of Science ®Google Scholar